Present status of animal clinical pathology examinations in the Japanese Pharmaceutical Manufacturers Association.
This paper will review the current status of animal clinical pathology in Japan using data obtained during a survey conducted by the Japanese Pharmaceutical Manufacturers Association (JPMA). I am presenting this information as a representative of the Non-Clinical Evaluation Committee of the JPMA. Two co-workers, Dr. Nomura of Daiichi Pharmaceutical Co., Ltd., and Dr. Unno of Kanebo Co., Ltd., are also involved in this effort. Investigating and discussing the various problems concerning animal clinical pathology is timely and truly heartening, and we expect this information exchange in the animal clinical pathology field to continue.
Matsuzawa
T
T
Safety Research Laboratories, Yamanouchi Pharmaceutical Co., Ltd., Tokyo, Japan.
D000818:Animals; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D007564:Japan; D010338:Pathology, Clinical / Q000639:trends*; D012957:Societies, Pharmaceutical